OCLN抗体,Rabbit Polyclonal OCLN Antibody
  • OCLN抗体,Rabbit Polyclonal OCLN Antibody
  • OCLN抗体,Rabbit Polyclonal OCLN Antibody
  • OCLN抗体,Rabbit Polyclonal OCLN Antibody

OCLN抗体

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 湖北
更新日期 2025-05-11
QQ交谈 微信洽谈

产品详情

中文名称:OCLN抗体英文名称:Rabbit Polyclonal OCLN Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 1731 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: OCLN
2025-05-11 OCLN抗体 Rabbit Polyclonal OCLN Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 1731 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesBLCPMG; PTORCH1; PPP1R115
WB Predicted band size59 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human OCLN
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Mouse liver tissue lysate, Primary antibody: P00583(OCLN Antibody) at dilution 1/550, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 30 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P00583(OCLN Antibody) at dilution 1/70. (Original magnification: ×200)    


           

参考文献

以下是3篇与OCLN抗体相关的研究文献概览:

1. **"Occludin: a novel integral membrane protein localizing at tight junctions"**

*作者:Furuse M, Hirase T, Itoh M, et al.*

摘要:该研究首次发现并命名了Occludin(OCLN),利用特异性抗体证实其定位在细胞紧密连接处,揭示了其在维持上皮屏障功能中的关键作用。

2. **"Antibody-based profiling of cerebrovascular endothelial cells for claudin-5 and occludin in Alzheimer's disease"**

*作者:Branyan TE, Sridharan S, Shah S, et al.*

摘要:通过OCLN抗体和Claudin-5抗体的免疫荧光分析,发现阿尔茨海默病模型中脑血管内皮细胞紧密连接蛋白表达异常,提示血脑屏障破坏机制。

3. **"Development and validation of monoclonal antibodies specific for human occludin isoforms"**

*作者:Runkle EA, Mu D.*

摘要:研究团队开发了针对人类OCLN不同亚型的单克隆抗体,验证了其特异性在Western blot和免疫组化中的应用,为亚型功能研究提供工具。

注:以上内容为基于领域知识的模拟文献概括,实际文献请通过PubMed或Google Scholar以关键词“occludin antibody”检索获取最新研究。

       

背景信息

Occludin (OCLN) is a key transmembrane protein component of tight junctions (TJs), specialized cell-cell adhesion structures critical for maintaining epithelial and endothelial barrier integrity. First identified in 1993. OCLN spans the plasma membrane four times, with both N- and C-termini located intracellularly. It interacts with cytoplasmic scaffolding proteins like ZO-1 to anchor TJs to the actin cytoskeleton. While its exact functional mechanisms remain debated, OCLN contributes to paracellular barrier formation, cell polarity, and signal transduction.

OCLN antibodies are essential tools for studying TJ dynamics in physiological and pathological contexts. They enable detection of OCLN expression/localization through techniques like immunofluorescence, Western blotting, and immunohistochemistry. Researchers use these antibodies to investigate barrier dysfunction in diseases such as inflammatory bowel disease, cancer metastasis (via epithelial-mesenchymal transition), and neurological disorders involving blood-brain barrier leakage. Species-specific and isoform-targeting antibodies (e.g., recognizing phosphorylated forms) help dissect post-translational regulation of OCLN during processes like hypoxia or immune cell transmigration.

Notably, OCLN knockout models show viable but leaky epithelial barriers, suggesting compensatory mechanisms by other TJ proteins like claudins. This underscores the importance of antibody validation using appropriate controls (e.g., knockout tissues) to ensure specificity. Commercial OCLN antibodies often differ in epitope recognition, requiring careful selection based on experimental needs.

       
关键字: OCLN抗体;OCLN;OCLN Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。
成立日期 2024-06-24 (2年) 注册资本 50万(元)
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 中间体,化学试剂 经营模式 贸易,工厂,试剂,定制,服务
  • 湖北瑞和宁生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:50万(元)
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:中间体。试剂
  • 公司地址:江汉区
询盘

店内推荐

OCLN抗体相关厂家报价

产品名称 价格   公司名称 报价日期
¥1280
湖北艾普蒂生物工程有限公司
2025-06-04
¥1098
VIP4年
上海沪震实业有限公司
2026-01-20
¥960.00
VIP10年
北京索莱宝科技有限公司
2026-01-19
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.